CA Stock MarketDetailed Quotes

ASP Acerus Pharmaceuticals Corp

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Jul 29 09:30 ET
0Market Cap0.00P/E (TTM)

Acerus Pharmaceuticals Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-74.67%-7.88M
24.95%-6.05M
-26.13%-4.66M
-6.09%-23.52M
-42.93%-7.26M
33.06%-4.51M
-39.76%-8.06M
19.47%-3.7M
-94.74%-22.17M
-13.35%-5.08M
Net income from continuing operations
14.80%-4.17M
-12.23%-7.94M
45.81%-6.95M
-38.46%-33.82M
-27.03%-9.02M
30.51%-4.9M
-26.02%-7.07M
-175.06%-12.83M
-51.43%-24.42M
-82.93%-7.1M
Operating gains losses
-5,086.21%-3.01M
-3.74%-111K
3.60%144K
-104.10%-60K
-102.09%-34K
-52.63%-58K
-222.99%-107K
164.95%139K
324.58%1.46M
515.05%1.63M
Depreciation and amortization
-28.75%57K
-78.63%56K
-77.99%57K
-32.57%681K
-68.38%80K
-67.61%80K
2.75%262K
1.57%259K
-9.74%1.01M
0.80%253K
Asset impairment expenditure
----
----
----
--1.66M
----
----
----
----
----
----
Remuneration paid in stock
-71.17%96K
2.27%180K
-18.56%237K
67.43%1.1M
28.26%295K
89.20%333K
-13.30%176K
546.67%291K
271.59%654K
1,669.23%230K
Other non cashItems
494.94%1.53M
393.27%1M
-88.84%725K
243.37%6.52M
-60.63%113K
-33.25%257K
-189.53%-342K
667.85%6.5M
-24.96%1.9M
-56.78%287K
Change In working capital
-965.92%-2.38M
178.05%761K
-42.18%1.12M
114.59%404K
7.57%-342K
51.31%-223K
9.81%-975K
326.05%1.94M
-115.99%-2.77M
67.29%-370K
-Change in receivables
88.15%-104K
-55.20%-388K
-155.22%-217K
907.75%1.04M
2,592.42%1.78M
-94.25%-878K
-227.55%-250K
544.26%393K
-125.15%-129K
-69.01%66K
-Change in inventory
-487.76%-570K
-516.67%-111K
225.76%166K
-179.85%-2.29M
-456.54%-2.29M
16.67%147K
98.79%-18K
-34.69%-132K
-213.75%-819K
682.93%642K
-Change in prepaid assets
116.89%112K
932.79%508K
-469.81%-302K
-369.92%-359K
129.67%418K
9.43%-663K
-103.68%-61K
94.57%-53K
112.74%133K
142.03%182K
-Change in payables and accrued expense
-248.93%-1.74M
225.85%813K
-14.92%1.48M
203.02%2.01M
80.32%-248K
95.17%1.17M
55.36%-646K
1,034.64%1.74M
-32.83%-1.95M
-26.89%-1.26M
-Change in other working capital
---71K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-74.67%-7.88M
24.95%-6.05M
-26.13%-4.66M
-6.09%-23.52M
-42.93%-7.26M
33.06%-4.51M
-39.76%-8.06M
19.47%-3.7M
-94.74%-22.17M
-13.35%-5.08M
Investing cash flow
Cash flow from continuing investing activities
-394K
-1,947.73%-813K
-695K
-16K
-60K
0
44K
0
Net PPE purchase and sale
--0
--0
---90K
---16K
---60K
--0
--44K
--0
----
----
Net intangibles purchas and sale
---394K
---813K
---605K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---394K
-1,947.73%-813K
---695K
---16K
---60K
--0
--44K
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
139.39%10M
-15.88%4.58M
2,439.45%6.76M
-35.04%16.54M
-23.98%7.2M
879.66%4.18M
1,313.36%5.45M
-101.70%-289K
91.47%25.46M
54.44%9.47M
Net issuance payments of debt
126.95%9.99M
-19.28%4.6M
28,850.00%6.9M
2,177.41%17.47M
2,861.19%7.4M
1,700.00%4.4M
23,829.17%5.7M
91.24%-24K
-107.36%-841K
-104.14%-268K
Net common stock issuance
----
----
----
----
----
----
----
----
730.72%27.83M
--10.01M
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Interest paid (cash flow from financing activities)
108.14%18K
94.33%-14K
47.55%-139K
35.01%-932K
26.02%-199K
21.63%-221K
41.88%-247K
42.14%-265K
2.71%-1.43M
22.48%-269K
Net other financing activities
----
----
----
----
----
----
----
----
---94K
--0
Cash from discontinued financing activities
Financing cash flow
139.39%10M
-15.88%4.58M
2,439.45%6.76M
-35.04%16.54M
-23.98%7.2M
879.66%4.18M
1,313.36%5.45M
-101.70%-289K
91.47%25.46M
54.44%9.47M
Net cash flow
Beginning cash position
-50.60%1.29M
-31.06%3.56M
-76.41%2.16M
56.19%9.15M
-52.22%2.27M
-78.36%2.6M
-71.68%5.17M
56.19%9.15M
53.04%5.86M
16.19%4.76M
Current changes in cash
625.45%1.73M
11.23%-2.28M
135.20%1.4M
-312.39%-6.99M
-102.59%-114K
95.46%-330K
58.73%-2.56M
-132.19%-3.99M
82.34%3.29M
165.62%4.4M
End cash Position
32.86%3.02M
-50.60%1.29M
-31.06%3.56M
-76.41%2.16M
-76.41%2.16M
-52.22%2.27M
-78.36%2.6M
-71.68%5.17M
56.19%9.15M
56.19%9.15M
Free cash from
-83.41%-8.27M
14.99%-6.86M
-44.93%-5.36M
-6.41%-23.59M
-44.11%-7.32M
33.06%-4.51M
-39.97%-8.07M
19.47%-3.7M
-92.82%-22.17M
-13.35%-5.08M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -74.67%-7.88M24.95%-6.05M-26.13%-4.66M-6.09%-23.52M-42.93%-7.26M33.06%-4.51M-39.76%-8.06M19.47%-3.7M-94.74%-22.17M-13.35%-5.08M
Net income from continuing operations 14.80%-4.17M-12.23%-7.94M45.81%-6.95M-38.46%-33.82M-27.03%-9.02M30.51%-4.9M-26.02%-7.07M-175.06%-12.83M-51.43%-24.42M-82.93%-7.1M
Operating gains losses -5,086.21%-3.01M-3.74%-111K3.60%144K-104.10%-60K-102.09%-34K-52.63%-58K-222.99%-107K164.95%139K324.58%1.46M515.05%1.63M
Depreciation and amortization -28.75%57K-78.63%56K-77.99%57K-32.57%681K-68.38%80K-67.61%80K2.75%262K1.57%259K-9.74%1.01M0.80%253K
Asset impairment expenditure --------------1.66M------------------------
Remuneration paid in stock -71.17%96K2.27%180K-18.56%237K67.43%1.1M28.26%295K89.20%333K-13.30%176K546.67%291K271.59%654K1,669.23%230K
Other non cashItems 494.94%1.53M393.27%1M-88.84%725K243.37%6.52M-60.63%113K-33.25%257K-189.53%-342K667.85%6.5M-24.96%1.9M-56.78%287K
Change In working capital -965.92%-2.38M178.05%761K-42.18%1.12M114.59%404K7.57%-342K51.31%-223K9.81%-975K326.05%1.94M-115.99%-2.77M67.29%-370K
-Change in receivables 88.15%-104K-55.20%-388K-155.22%-217K907.75%1.04M2,592.42%1.78M-94.25%-878K-227.55%-250K544.26%393K-125.15%-129K-69.01%66K
-Change in inventory -487.76%-570K-516.67%-111K225.76%166K-179.85%-2.29M-456.54%-2.29M16.67%147K98.79%-18K-34.69%-132K-213.75%-819K682.93%642K
-Change in prepaid assets 116.89%112K932.79%508K-469.81%-302K-369.92%-359K129.67%418K9.43%-663K-103.68%-61K94.57%-53K112.74%133K142.03%182K
-Change in payables and accrued expense -248.93%-1.74M225.85%813K-14.92%1.48M203.02%2.01M80.32%-248K95.17%1.17M55.36%-646K1,034.64%1.74M-32.83%-1.95M-26.89%-1.26M
-Change in other working capital ---71K------------------------------------
Cash from discontinued investing activities
Operating cash flow -74.67%-7.88M24.95%-6.05M-26.13%-4.66M-6.09%-23.52M-42.93%-7.26M33.06%-4.51M-39.76%-8.06M19.47%-3.7M-94.74%-22.17M-13.35%-5.08M
Investing cash flow
Cash flow from continuing investing activities -394K-1,947.73%-813K-695K-16K-60K044K0
Net PPE purchase and sale --0--0---90K---16K---60K--0--44K--0--------
Net intangibles purchas and sale ---394K---813K---605K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow ---394K-1,947.73%-813K---695K---16K---60K--0--44K--0--0----
Financing cash flow
Cash flow from continuing financing activities 139.39%10M-15.88%4.58M2,439.45%6.76M-35.04%16.54M-23.98%7.2M879.66%4.18M1,313.36%5.45M-101.70%-289K91.47%25.46M54.44%9.47M
Net issuance payments of debt 126.95%9.99M-19.28%4.6M28,850.00%6.9M2,177.41%17.47M2,861.19%7.4M1,700.00%4.4M23,829.17%5.7M91.24%-24K-107.36%-841K-104.14%-268K
Net common stock issuance --------------------------------730.72%27.83M--10.01M
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Interest paid (cash flow from financing activities) 108.14%18K94.33%-14K47.55%-139K35.01%-932K26.02%-199K21.63%-221K41.88%-247K42.14%-265K2.71%-1.43M22.48%-269K
Net other financing activities -----------------------------------94K--0
Cash from discontinued financing activities
Financing cash flow 139.39%10M-15.88%4.58M2,439.45%6.76M-35.04%16.54M-23.98%7.2M879.66%4.18M1,313.36%5.45M-101.70%-289K91.47%25.46M54.44%9.47M
Net cash flow
Beginning cash position -50.60%1.29M-31.06%3.56M-76.41%2.16M56.19%9.15M-52.22%2.27M-78.36%2.6M-71.68%5.17M56.19%9.15M53.04%5.86M16.19%4.76M
Current changes in cash 625.45%1.73M11.23%-2.28M135.20%1.4M-312.39%-6.99M-102.59%-114K95.46%-330K58.73%-2.56M-132.19%-3.99M82.34%3.29M165.62%4.4M
End cash Position 32.86%3.02M-50.60%1.29M-31.06%3.56M-76.41%2.16M-76.41%2.16M-52.22%2.27M-78.36%2.6M-71.68%5.17M56.19%9.15M56.19%9.15M
Free cash from -83.41%-8.27M14.99%-6.86M-44.93%-5.36M-6.41%-23.59M-44.11%-7.32M33.06%-4.51M-39.97%-8.07M19.47%-3.7M-92.82%-22.17M-13.35%-5.08M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg